Skip to Content

  • Search

View Additional Section Content

HCRI-DAPT - Prospective, multi-center, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous coronary intervention (PCI) with either drug-eluting stent or bare metal stent (BMS) placement for the treatment of coronary artery lesions.

Principal Investigator(s)
Robert A. Watson, III, M.D.
Asoka Balaratna, M.D. (Sub-Investigator)
Marc C. Cohen, M.D. (Sub-Investigator)
Peter B. Frechie, D.O. (Sub-Investigator)
Bruce D. Klugherz, M.D. (Sub-Investigator)

Clinical Trial Categories

  • Cardiology
Contact
Beth Bishop at 215-517-1027

Location

  • Abington Medical Specialists

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details